生物活性 | |||
---|---|---|---|
描述 | RA190 forms a covalent bond with cysteine 88 on the RPN13 ubiquitin receptor within the 19S regulatory particle, leading to proteasome inhibition and a swift build-up of polyubiquitinated proteins. It is effective against multiple myeloma (MM) cell lines, including those that are bortezomib-resistant, by inducing apoptosis through endoplasmic reticulum stress. Additionally, RA190 impedes the degradation of human papillomavirus (HPV) E6 oncoprotein targets, resulting in the selective elimination of HPV-transformed cells[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.68mL 0.34mL 0.17mL |
8.38mL 1.68mL 0.84mL |
16.76mL 3.35mL 1.68mL |
参考文献 |
---|